Catalent
CTLT
#1601
Rank
C$14.99 B
Marketcap
$82.63
Share price
-0.85%
Change (1 day)
75.72%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Cash on Hand

Cash on Hand as of June 2024 : C$0.40 Billion

According to Catalent's latest financial reports the company has C$0.40 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Catalent - Cash on Hand chart (from 2013 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-06-30C$0.37 B-46.47%
2022-06-30C$0.69 B-42.18%
2021-06-30C$1.19 B-7.9%
2020-06-30C$1.30 B187.08%
2019-06-30C$0.45 B-15.95%
2018-06-30C$0.53 B35.27%
2017-06-30C$0.39 B122.43%
2016-06-30C$0.17 B-4.54%
2015-06-30C$0.18 B136.66%
2014-06-30C$79.35 M-29.1%
2013-06-30C$0.11 B-20.92%
2012-06-30C$0.14 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$0.48 B 20.13%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.23 B-40.32%๐Ÿ‡บ๐Ÿ‡ธ USA
C$2.75 B 585.40%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
C$0.44 B 11.67%๐Ÿ‡บ๐Ÿ‡ธ USA